ArticleFrontiers in oncology2023

The multiple combination of Paclitaxel, Ramucirumab and Elacridar reverses the paclitaxel-mediated resistance in gastric cancer cell lines.

Annalisa Schirizzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.